Antithymocyte immunoglobulin (rabbit) Completed Phase 2 Trials for Agnogenic Myeloid Metaplasia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00475020Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome